- •We systematically reviewed MS incidence and prevalence in Africa, Asia, Australia, and New Zealand.
- •Highest prevalence was observed in Australian-born Australians and lowest prevalence was seen in South African Blacks.
- •Prevalence increased over time in many countries.
- •MS prevalence increased with increasing latitude only in some regions.
- •Prevalence varied significantly with ethnicity.
Studies of multiple sclerosis (MS) incidence and prevalence from Africa, Asia, Australia and New Zealand are relatively scarce. We systematically reviewed MS incidence and prevalence in these regions including a standardized evaluation of study quality.
We searched MEDLINE and EMBASE databases for studies of MS prevalence or incidence in Africa, Asia, Australia and New Zealand published in English or French between January 1, 1985 and January 31, 2011. Study quality was assessed using a standardized tool. All steps of the review were performed in duplicate.
Of 3925 citations identified, 28 studies met inclusion criteria and 21 of these were from Asia. Quality scores ranged from 1/8 to 8/8; the lowest scores were observed in studies from Asia (median 4/8, IQR 3,6). Prevalence was lowest in South African Blacks (0.22/100,000) and highest amongst Australian-born individuals in Australia (125/100,000). Prevalence increased over time in many countries. MS prevalence increased with increasing latitude only in some regions, and prevalence varied significantly with ethnicity. Eight studies reported incidence, which ranged from 0.67/100,000/year in Taiwan to 3.67/100,00/year in Australia.
This comprehensive study provides an update of MS epidemiology in Africa, Asia, Australia, and New Zealand. Incidence and prevalence were lowest in Africa and Asia and highest in Australia, but many Asian studies were of poor quality. Use of consistent case ascertainment methods, standardized data collection tools, and similar outcomes would all improve study quality and comparability. The underlying basis of observed ethnic differences is an important area for future study.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Multiple Sclerosis and Related Disorders
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians.Journal of the neurological sciences. 1990; 100: 137-141
- Temporal trends in the incidence of multiple sclerosis: a systematic review.Neurology. 2008; 71: 129-135
- Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence.European Neurology. 2005; 53: 125-131
- Multiple sclerosis frequency in Israel's diverse populations.Neurology. 2006; 66: 1061-1066
- Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study.Journal of the Neurological Sciences. 2003; 213: 1-6
- Prevalence of multiple sclerosis in the Parsis of Bombay.Neurology. 1988; 38: 727-729
- Multiple sclerosis in KwaZulu Natal, South Africa: an epidemiological and clinical study.Multiple Sclerosis. 2007; 13: 1095-1099
- Guidelines for evaluating prevalence studies.Evidence-Based Mental Health. 1998; 1: 37-39
- Multiple sclerosis is more prevalent in northern New Zealand than previously reported.International Medical Journal. 2003; 33: 79-83
- A population-based survey of multiple sclerosis in Shanghai, China.Neurology. 2007; 68: 1495-1500
- Multiple sclerosis in Jordan: A clinical and epidemiological study.Journal of Neurology. 2006; 253: 1210-1216
- Prevalence of multiple sclerosis in Isfahan, Iran.Neuroepidemiology. 2006; 27: 39-44
- Incidence and prevalence of multiple sclerosis in the Americas: a systematic review.Neuroepidemiology. 2013; 40: 195-210
- Diagnosis of multiple sclerosis: comparison of the Poser criteria and the new McDonald criteria.Acta Neurologica Scandinavica. 2004; 109: 385-389
- The epidemiology of multiple sclerosis in Devon: a comparison of the new and old classification criteria.Journal of Neurology, Neurosurgery, and Psychiatry. 2004; 75: 56-60
Ghandehari K, Riasi HR, Nourian A, Boroumand AR. Prevalence of multiple sclerosis in north east of Iran. Multiple Sclerosis 2010;16:1525-6.
- Increasing prevalence and incidence of multiple sclerosis in northern Japan.Multiple Sclerosis. 2008; 14: 887-892
- The prevalence and clinical characteristics of MS in northern Japan.Journal of the Neurological Sciences. 2003; 211: 49-53
- Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan.Journal of the Neurological Sciences. 2003; 214: 7-9
- The frequency of multiple sclerosis in jewish and arab populations in greater jerusalem.Neuroepidemiology. 2003; 22: 82-86
- Prevalence of multiple sclerosis in Korea.Neurology. 2010; 75: 1432-1438
- Population-based epidemiological study of neurological diseases in Taiwan: I. Creutzfeldt-Jakob disease and multiple sclerosis.Neuroepidemiology. 2009; 33: 247-253
- Epidemiological study of multiple sclerosis in Hong Kong Chinese: questionnaire survey.Hong Kong Medical Journal. 2002; 8: 77-80
- Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.Annals of Neurology. 2001; 50: 121-127
- Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years.Multiple Sclerosis. 2009; 15: 159-173
- Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”.Annals of Neurology. 2005; 58: 840-846
- New diagnostic criteria for multiple sclerosis: guidelines for research protocols.Annals of Neurology. 1983; 13: 227-231
- Inflammatory bowel disease in Asia: a systematic review.Journal of Gastroenterology and Hepatology. 2012; 27: 1266-1280
- Criteria for the clinical diagnosis of multiple sclerosis.Neurology. 1976; 26: 20-22
- A new multiple sclerosis epidemic? A pilot survey.South African Medical Journal. 1985; 68: 162-163
- Multiple sclerosis in Isfahan, Iran.International Review of Neurobiology. 2007; 79: 357-375
- Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.European Neurology. 2010; 64: 331-336
- Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis.Annals of the New York Academy of Sciences. 1965; 122: 552-568
- Prevalence survey of multiple sclerosis in the Australian Capital Territory.International Medical Journal. 2001; 31: 161-167
- Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis.Journal of Neurology, Neurosurgery, and Psychiatry. 2011; 82: 1132-1141
- Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009.Journal of Neurology, Neurosurgery, and Psychiatry. 2011; 82: 180-187
- MS prevalence in New Zealand, an ethnically and latitudinally diverse country.Multiple Sclerosis. 2010; 16: 1422-1431
- Primary progressive multiple sclerosis.Brain: A Journal of Neurology. 1997; 120: 1085-1096
- Multiple sclerosis in Taiwan.Journal of the Chinese Medical Association. 2004; 67: 500-505
- Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey.Neuroepidemiology. 2006; 27: 17-21
- Revised diagnostic criteria for neuromyelitis optica.Neurology. 2006; 66: 1485-1489
- Multiple sclerosis amongst Chinese in Hong Kong.Brain: A Journal of Neurology. 112. 1989: 1445-1467
Published online: July 29, 2013
Accepted: June 27, 2013
Received: May 10, 2013
© 2013 Elsevier B.V. Published by Elsevier Inc. All rights reserved.